H.C. Wainwright: BioMarin’s (BMRN) Amicus Acquisition Stabilizes Cash Flow While Voxzogo Remains Near-Term Driver
Yahoo Finance·2026-01-01 11:29

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the best NASDAQ stocks to buy in 2026. On December 22, H.C. Wainwright raised the firm’s price target on BioMarin to 60from60 from 55 with a Neutral rating on the shares. This sentiment was announced amid the acquisition of Amicus Therapeutics Inc. (NASDAQ:FOLD), which the firm described as a move that stabilizes long-term cash flows, though H.C. Wainwright also noted that peak sales won’t materialize until the 2030s. Therefore, Voxzogo will remain the prima ...